Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Journal
-
- The Lancet Oncology
-
The Lancet Oncology 17 (12), 1643-1652, 2016-12
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1362262945258064384
-
- ISSN
- 14702045
-
- Data Source
-
- Crossref